nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—CYP3A4—Temozolomide—brain cancer	0.123	0.417	CbGbCtD
Prednisone—CYP3A4—Lomustine—brain cancer	0.104	0.355	CbGbCtD
Prednisone—ABCB1—Etoposide—brain cancer	0.0421	0.143	CbGbCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0406	0.282	CbGpPWpGaD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0282	0.195	CbGpPWpGaD
Prednisone—CYP3A4—Etoposide—brain cancer	0.0252	0.0857	CbGbCtD
Prednisone—HSD11B1—telencephalon—brain cancer	0.00848	0.077	CbGeAlD
Prednisone—HSD11B1—gonad—brain cancer	0.00708	0.0642	CbGeAlD
Prednisone—HSD11B1—pituitary gland—brain cancer	0.0069	0.0627	CbGeAlD
Prednisone—HSD11B1—medulla oblongata—brain cancer	0.00666	0.0605	CbGeAlD
Prednisone—HSD11B1—midbrain—brain cancer	0.00609	0.0553	CbGeAlD
Prednisone—HSD11B1—spinal cord—brain cancer	0.00594	0.0539	CbGeAlD
Prednisone—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00537	0.0372	CbGpPWpGaD
Prednisone—HSD11B1—endocrine gland—brain cancer	0.00535	0.0485	CbGeAlD
Prednisone—HSD11B1—head—brain cancer	0.00528	0.0479	CbGeAlD
Prednisone—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00488	0.0339	CbGpPWpGaD
Prednisone—HSD11B1—central nervous system—brain cancer	0.00482	0.0437	CbGeAlD
Prednisone—HSD11B1—cerebellum—brain cancer	0.00471	0.0428	CbGeAlD
Prednisone—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00416	0.0289	CbGpPWpGaD
Prednisone—HSD11B1—brain—brain cancer	0.00383	0.0347	CbGeAlD
Prednisone—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.00344	0.0239	CbGpPWpGaD
Prednisone—NR3C1—hindbrain—brain cancer	0.00315	0.0286	CbGeAlD
Prednisone—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00258	0.0179	CbGpPWpGaD
Prednisone—SLCO1A2—telencephalon—brain cancer	0.00256	0.0233	CbGeAlD
Prednisone—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00248	0.0172	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00222	0.0154	CbGpPWpGaD
Prednisone—SLCO1A2—medulla oblongata—brain cancer	0.00201	0.0183	CbGeAlD
Prednisone—SLCO1A2—midbrain—brain cancer	0.00184	0.0167	CbGeAlD
Prednisone—NR3C1—brainstem—brain cancer	0.00181	0.0164	CbGeAlD
Prednisone—SLCO1A2—spinal cord—brain cancer	0.0018	0.0163	CbGeAlD
Prednisone—ABCB1—blood vessel—brain cancer	0.00177	0.0161	CbGeAlD
Prednisone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00177	0.0123	CbGpPWpGaD
Prednisone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00173	0.012	CbGpPWpGaD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00165	0.0114	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00162	0.0112	CbGpPWpGaD
Prednisone—SLCO1A2—endocrine gland—brain cancer	0.00162	0.0147	CbGeAlD
Prednisone—NR3C1—telencephalon—brain cancer	0.0016	0.0146	CbGeAlD
Prednisone—SLCO1A2—head—brain cancer	0.0016	0.0145	CbGeAlD
Prednisone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00155	0.0108	CbGpPWpGaD
Prednisone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00149	0.0103	CbGpPWpGaD
Prednisone—SLCO1A2—central nervous system—brain cancer	0.00146	0.0132	CbGeAlD
Prednisone—Pancreatitis—Hydroxyurea—brain cancer	0.00144	0.00318	CcSEcCtD
Prednisone—SLCO1A2—cerebellum—brain cancer	0.00142	0.0129	CbGeAlD
Prednisone—Amnesia—Temozolomide—brain cancer	0.00141	0.00312	CcSEcCtD
Prednisone—Flushing—Procarbazine—brain cancer	0.00141	0.00312	CcSEcCtD
Prednisone—Skin exfoliation—Etoposide—brain cancer	0.00139	0.00309	CcSEcCtD
Prednisone—Purpura—Temozolomide—brain cancer	0.00137	0.00304	CcSEcCtD
Prednisone—Neuropathy—Etoposide—brain cancer	0.00137	0.00304	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00137	0.00304	CcSEcCtD
Prednisone—Neutropenia—Hydroxyurea—brain cancer	0.00137	0.00304	CcSEcCtD
Prednisone—Arrhythmia—Procarbazine—brain cancer	0.00135	0.003	CcSEcCtD
Prednisone—Body temperature increased—Lomustine—brain cancer	0.00134	0.00297	CcSEcCtD
Prednisone—NR3C1—gonad—brain cancer	0.00134	0.0122	CbGeAlD
Prednisone—Alopecia—Procarbazine—brain cancer	0.00134	0.00297	CcSEcCtD
Prednisone—Oesophagitis—Etoposide—brain cancer	0.00133	0.00296	CcSEcCtD
Prednisone—Weight increased—Hydroxyurea—brain cancer	0.00133	0.00295	CcSEcCtD
Prednisone—Face oedema—Carmustine—brain cancer	0.00132	0.00293	CcSEcCtD
Prednisone—NR3C1—pituitary gland—brain cancer	0.00131	0.0119	CbGeAlD
Prednisone—Affect lability—Temozolomide—brain cancer	0.0013	0.00289	CcSEcCtD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.0013	0.00904	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.0013	0.00899	CbGpPWpGaD
Prednisone—CYP2C19—endocrine gland—brain cancer	0.00129	0.0118	CbGeAlD
Prednisone—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00128	0.00284	CcSEcCtD
Prednisone—Face oedema—Temozolomide—brain cancer	0.00128	0.00283	CcSEcCtD
Prednisone—Sepsis—Etoposide—brain cancer	0.00127	0.00281	CcSEcCtD
Prednisone—NR3C1—medulla oblongata—brain cancer	0.00126	0.0114	CbGeAlD
Prednisone—Mood swings—Temozolomide—brain cancer	0.00125	0.00278	CcSEcCtD
Prednisone—Hypokalaemia—Carmustine—brain cancer	0.00125	0.00276	CcSEcCtD
Prednisone—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00124	0.00859	CbGpPWpGaD
Prednisone—Anaemia—Procarbazine—brain cancer	0.00122	0.0027	CcSEcCtD
Prednisone—Dry skin—Temozolomide—brain cancer	0.00121	0.00269	CcSEcCtD
Prednisone—Muscular weakness—Carmustine—brain cancer	0.00121	0.00268	CcSEcCtD
Prednisone—Hypokalaemia—Temozolomide—brain cancer	0.00121	0.00267	CcSEcCtD
Prednisone—Syncope—Procarbazine—brain cancer	0.00118	0.00262	CcSEcCtD
Prednisone—Haemoglobin—Hydroxyurea—brain cancer	0.00118	0.00261	CcSEcCtD
Prednisone—Haemorrhage—Hydroxyurea—brain cancer	0.00117	0.0026	CcSEcCtD
Prednisone—Cardiac failure congestive—Etoposide—brain cancer	0.00117	0.00259	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00117	0.00259	CcSEcCtD
Prednisone—Muscular weakness—Temozolomide—brain cancer	0.00117	0.00259	CcSEcCtD
Prednisone—Hallucination—Hydroxyurea—brain cancer	0.00117	0.00259	CcSEcCtD
Prednisone—Loss of consciousness—Procarbazine—brain cancer	0.00116	0.00257	CcSEcCtD
Prednisone—SLCO1A2—brain—brain cancer	0.00116	0.0105	CbGeAlD
Prednisone—Abdominal distension—Temozolomide—brain cancer	0.00115	0.00255	CcSEcCtD
Prednisone—NR3C1—midbrain—brain cancer	0.00115	0.0105	CbGeAlD
Prednisone—ALB—brain—brain cancer	0.00115	0.0104	CbGeAlD
Prednisone—Convulsion—Procarbazine—brain cancer	0.00114	0.00253	CcSEcCtD
Prednisone—Hypertension—Procarbazine—brain cancer	0.00114	0.00252	CcSEcCtD
Prednisone—NR3C1—spinal cord—brain cancer	0.00112	0.0102	CbGeAlD
Prednisone—Myalgia—Procarbazine—brain cancer	0.00112	0.00249	CcSEcCtD
Prednisone—Arthralgia—Procarbazine—brain cancer	0.00112	0.00249	CcSEcCtD
Prednisone—Anxiety—Procarbazine—brain cancer	0.00112	0.00248	CcSEcCtD
Prednisone—Sweating increased—Temozolomide—brain cancer	0.00112	0.00247	CcSEcCtD
Prednisone—Neutropenia—Carmustine—brain cancer	0.00111	0.00245	CcSEcCtD
Prednisone—Cardiac failure—Etoposide—brain cancer	0.00109	0.00241	CcSEcCtD
Prednisone—Vomiting—Lomustine—brain cancer	0.00108	0.00239	CcSEcCtD
Prednisone—Oedema—Procarbazine—brain cancer	0.00108	0.00239	CcSEcCtD
Prednisone—Neutropenia—Temozolomide—brain cancer	0.00107	0.00237	CcSEcCtD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00107	0.00743	CbGpPWpGaD
Prednisone—Infection—Procarbazine—brain cancer	0.00107	0.00237	CcSEcCtD
Prednisone—Hyperglycaemia—Carmustine—brain cancer	0.00107	0.00237	CcSEcCtD
Prednisone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00106	0.00739	CbGpPWpGaD
Prednisone—Angiopathy—Hydroxyurea—brain cancer	0.00106	0.00236	CcSEcCtD
Prednisone—Shock—Procarbazine—brain cancer	0.00106	0.00235	CcSEcCtD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00106	0.00733	CbGpPWpGaD
Prednisone—Erectile dysfunction—Temozolomide—brain cancer	0.00105	0.00234	CcSEcCtD
Prednisone—Depression—Carmustine—brain cancer	0.00105	0.00233	CcSEcCtD
Prednisone—Tachycardia—Procarbazine—brain cancer	0.00105	0.00233	CcSEcCtD
Prednisone—Weight increased—Temozolomide—brain cancer	0.00104	0.00231	CcSEcCtD
Prednisone—Hyperhidrosis—Procarbazine—brain cancer	0.00104	0.00231	CcSEcCtD
Prednisone—Alopecia—Hydroxyurea—brain cancer	0.00104	0.0023	CcSEcCtD
Prednisone—Weight decreased—Temozolomide—brain cancer	0.00104	0.00229	CcSEcCtD
Prednisone—Neuropathy peripheral—Carmustine—brain cancer	0.00104	0.00229	CcSEcCtD
Prednisone—Hyperglycaemia—Temozolomide—brain cancer	0.00103	0.00229	CcSEcCtD
Prednisone—Anorexia—Procarbazine—brain cancer	0.00103	0.00227	CcSEcCtD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00102	0.00711	CbGpPWpGaD
Prednisone—Erythema—Hydroxyurea—brain cancer	0.00102	0.00226	CcSEcCtD
Prednisone—Depression—Temozolomide—brain cancer	0.00102	0.00225	CcSEcCtD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00101	0.00704	CbGpPWpGaD
Prednisone—NR3C1—endocrine gland—brain cancer	0.00101	0.00919	CbGeAlD
Prednisone—Cardiac arrest—Etoposide—brain cancer	0.00101	0.00223	CcSEcCtD
Prednisone—Nausea—Lomustine—brain cancer	0.00101	0.00223	CcSEcCtD
Prednisone—Neuropathy peripheral—Temozolomide—brain cancer	0.001	0.00222	CcSEcCtD
Prednisone—NR3C1—head—brain cancer	0.000999	0.00907	CbGeAlD
Prednisone—HSD11B1—Metabolism—CYP2C9—brain cancer	0.000987	0.00685	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000984	0.00683	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000981	0.00217	CcSEcCtD
Prednisone—Insomnia—Procarbazine—brain cancer	0.000974	0.00216	CcSEcCtD
Prednisone—Paraesthesia—Procarbazine—brain cancer	0.000967	0.00214	CcSEcCtD
Prednisone—Haemoglobin—Carmustine—brain cancer	0.000953	0.00211	CcSEcCtD
Prednisone—Haemorrhage—Carmustine—brain cancer	0.000948	0.0021	CcSEcCtD
Prednisone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000947	0.0021	CcSEcCtD
Prednisone—Anaemia—Hydroxyurea—brain cancer	0.000944	0.00209	CcSEcCtD
Prednisone—Hallucination—Carmustine—brain cancer	0.000943	0.00209	CcSEcCtD
Prednisone—Decreased appetite—Procarbazine—brain cancer	0.000936	0.00207	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Etoposide—brain cancer	0.000935	0.00207	CcSEcCtD
Prednisone—Connective tissue disorder—Carmustine—brain cancer	0.000932	0.00206	CcSEcCtD
Prednisone—Fatigue—Procarbazine—brain cancer	0.000928	0.00206	CcSEcCtD
Prednisone—Haemoglobin—Temozolomide—brain cancer	0.000921	0.00204	CcSEcCtD
Prednisone—Malaise—Hydroxyurea—brain cancer	0.000921	0.00204	CcSEcCtD
Prednisone—Constipation—Procarbazine—brain cancer	0.000921	0.00204	CcSEcCtD
Prednisone—Haemorrhage—Temozolomide—brain cancer	0.000916	0.00203	CcSEcCtD
Prednisone—NR3C1—central nervous system—brain cancer	0.000912	0.00828	CbGeAlD
Prednisone—Hallucination—Temozolomide—brain cancer	0.000912	0.00202	CcSEcCtD
Prednisone—Connective tissue disorder—Temozolomide—brain cancer	0.0009	0.00199	CcSEcCtD
Prednisone—Sweating increased—Etoposide—brain cancer	0.000892	0.00198	CcSEcCtD
Prednisone—NR3C1—cerebellum—brain cancer	0.000892	0.00809	CbGeAlD
Prednisone—Feeling abnormal—Procarbazine—brain cancer	0.000887	0.00197	CcSEcCtD
Prednisone—Eye disorder—Carmustine—brain cancer	0.000886	0.00196	CcSEcCtD
Prednisone—Convulsion—Hydroxyurea—brain cancer	0.000885	0.00196	CcSEcCtD
Prednisone—Gastrointestinal pain—Procarbazine—brain cancer	0.00088	0.00195	CcSEcCtD
Prednisone—Flushing—Carmustine—brain cancer	0.00088	0.00195	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000868	0.00602	CbGpPWpGaD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000863	0.00191	CcSEcCtD
Prednisone—ABCB1—telencephalon—brain cancer	0.000859	0.0078	CbGeAlD
Prednisone—Discomfort—Hydroxyurea—brain cancer	0.000859	0.0019	CcSEcCtD
Prednisone—Neutropenia—Etoposide—brain cancer	0.000857	0.0019	CcSEcCtD
Prednisone—Eye disorder—Temozolomide—brain cancer	0.000856	0.0019	CcSEcCtD
Prednisone—Urticaria—Procarbazine—brain cancer	0.000855	0.00189	CcSEcCtD
Prednisone—Body temperature increased—Procarbazine—brain cancer	0.000851	0.00189	CcSEcCtD
Prednisone—Abdominal pain—Procarbazine—brain cancer	0.000851	0.00189	CcSEcCtD
Prednisone—Flushing—Temozolomide—brain cancer	0.00085	0.00188	CcSEcCtD
Prednisone—Arrhythmia—Carmustine—brain cancer	0.000847	0.00188	CcSEcCtD
Prednisone—HSD11B1—Metabolism—BSG—brain cancer	0.000839	0.00582	CbGpPWpGaD
Prednisone—Alopecia—Carmustine—brain cancer	0.000838	0.00186	CcSEcCtD
Prednisone—Oedema—Hydroxyurea—brain cancer	0.000833	0.00185	CcSEcCtD
Prednisone—Angiopathy—Temozolomide—brain cancer	0.000831	0.00184	CcSEcCtD
Prednisone—Mental disorder—Carmustine—brain cancer	0.000831	0.00184	CcSEcCtD
Prednisone—Infection—Hydroxyurea—brain cancer	0.000828	0.00183	CcSEcCtD
Prednisone—Immune system disorder—Temozolomide—brain cancer	0.000828	0.00183	CcSEcCtD
Prednisone—Erythema—Carmustine—brain cancer	0.000825	0.00183	CcSEcCtD
Prednisone—Malnutrition—Carmustine—brain cancer	0.000825	0.00183	CcSEcCtD
Prednisone—Nervous system disorder—Hydroxyurea—brain cancer	0.000817	0.00181	CcSEcCtD
Prednisone—Alopecia—Temozolomide—brain cancer	0.00081	0.00179	CcSEcCtD
Prednisone—Skin disorder—Hydroxyurea—brain cancer	0.000809	0.00179	CcSEcCtD
Prednisone—Acute coronary syndrome—Etoposide—brain cancer	0.000805	0.00178	CcSEcCtD
Prednisone—Mental disorder—Temozolomide—brain cancer	0.000803	0.00178	CcSEcCtD
Prednisone—Neuropathy peripheral—Etoposide—brain cancer	0.000801	0.00177	CcSEcCtD
Prednisone—Myocardial infarction—Etoposide—brain cancer	0.000801	0.00177	CcSEcCtD
Prednisone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.0008	0.00555	CbGpPWpGaD
Prednisone—Malnutrition—Temozolomide—brain cancer	0.000798	0.00177	CcSEcCtD
Prednisone—Erythema—Temozolomide—brain cancer	0.000798	0.00177	CcSEcCtD
Prednisone—Anorexia—Hydroxyurea—brain cancer	0.000794	0.00176	CcSEcCtD
Prednisone—Hypersensitivity—Procarbazine—brain cancer	0.000793	0.00176	CcSEcCtD
Prednisone—Vision blurred—Carmustine—brain cancer	0.000778	0.00172	CcSEcCtD
Prednisone—Asthenia—Procarbazine—brain cancer	0.000773	0.00171	CcSEcCtD
Prednisone—CYP3A4—endocrine gland—brain cancer	0.000766	0.00695	CbGeAlD
Prednisone—Anaemia—Carmustine—brain cancer	0.000763	0.00169	CcSEcCtD
Prednisone—Pruritus—Procarbazine—brain cancer	0.000762	0.00169	CcSEcCtD
Prednisone—Agitation—Carmustine—brain cancer	0.000759	0.00168	CcSEcCtD
Prednisone—Vision blurred—Temozolomide—brain cancer	0.000752	0.00167	CcSEcCtD
Prednisone—Ill-defined disorder—Temozolomide—brain cancer	0.00074	0.00164	CcSEcCtD
Prednisone—Anaemia—Temozolomide—brain cancer	0.000737	0.00163	CcSEcCtD
Prednisone—Diarrhoea—Procarbazine—brain cancer	0.000737	0.00163	CcSEcCtD
Prednisone—Dyspepsia—Hydroxyurea—brain cancer	0.000734	0.00163	CcSEcCtD
Prednisone—Agitation—Temozolomide—brain cancer	0.000733	0.00162	CcSEcCtD
Prednisone—Angioedema—Temozolomide—brain cancer	0.000729	0.00161	CcSEcCtD
Prednisone—Decreased appetite—Hydroxyurea—brain cancer	0.000724	0.0016	CcSEcCtD
Prednisone—NR3C1—brain—brain cancer	0.000724	0.00657	CbGeAlD
Prednisone—HSD11B1—Metabolism—IDH1—brain cancer	0.000722	0.00501	CbGpPWpGaD
Prednisone—Malaise—Temozolomide—brain cancer	0.000719	0.00159	CcSEcCtD
Prednisone—Fatigue—Hydroxyurea—brain cancer	0.000718	0.00159	CcSEcCtD
Prednisone—ABCB1—gonad—brain cancer	0.000717	0.00651	CbGeAlD
Prednisone—Vertigo—Temozolomide—brain cancer	0.000717	0.00159	CcSEcCtD
Prednisone—Convulsion—Carmustine—brain cancer	0.000715	0.00158	CcSEcCtD
Prednisone—Hypertension—Carmustine—brain cancer	0.000713	0.00158	CcSEcCtD
Prednisone—Constipation—Hydroxyurea—brain cancer	0.000713	0.00158	CcSEcCtD
Prednisone—Dizziness—Procarbazine—brain cancer	0.000712	0.00158	CcSEcCtD
Prednisone—Myalgia—Carmustine—brain cancer	0.000703	0.00156	CcSEcCtD
Prednisone—Anxiety—Carmustine—brain cancer	0.0007	0.00155	CcSEcCtD
Prednisone—ABCB1—pituitary gland—brain cancer	0.000699	0.00635	CbGeAlD
Prednisone—Convulsion—Temozolomide—brain cancer	0.000691	0.00153	CcSEcCtD
Prednisone—CYP3A4—central nervous system—brain cancer	0.00069	0.00626	CbGeAlD
Prednisone—Hypertension—Temozolomide—brain cancer	0.000689	0.00153	CcSEcCtD
Prednisone—Feeling abnormal—Hydroxyurea—brain cancer	0.000687	0.00152	CcSEcCtD
Prednisone—Eye disorder—Etoposide—brain cancer	0.000685	0.00152	CcSEcCtD
Prednisone—Vomiting—Procarbazine—brain cancer	0.000685	0.00152	CcSEcCtD
Prednisone—Flushing—Etoposide—brain cancer	0.00068	0.00151	CcSEcCtD
Prednisone—Myalgia—Temozolomide—brain cancer	0.000679	0.0015	CcSEcCtD
Prednisone—Arthralgia—Temozolomide—brain cancer	0.000679	0.0015	CcSEcCtD
Prednisone—Rash—Procarbazine—brain cancer	0.000679	0.0015	CcSEcCtD
Prednisone—Dermatitis—Procarbazine—brain cancer	0.000678	0.0015	CcSEcCtD
Prednisone—Anxiety—Temozolomide—brain cancer	0.000677	0.0015	CcSEcCtD
Prednisone—ABCB1—medulla oblongata—brain cancer	0.000675	0.00613	CbGeAlD
Prednisone—Headache—Procarbazine—brain cancer	0.000675	0.00149	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000674	0.00149	CcSEcCtD
Prednisone—Oedema—Carmustine—brain cancer	0.000674	0.00149	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000673	0.00467	CbGpPWpGaD
Prednisone—Discomfort—Temozolomide—brain cancer	0.000671	0.00149	CcSEcCtD
Prednisone—Infection—Carmustine—brain cancer	0.000669	0.00148	CcSEcCtD
Prednisone—Angiopathy—Etoposide—brain cancer	0.000665	0.00147	CcSEcCtD
Prednisone—Immune system disorder—Etoposide—brain cancer	0.000662	0.00147	CcSEcCtD
Prednisone—Body temperature increased—Hydroxyurea—brain cancer	0.000659	0.00146	CcSEcCtD
Prednisone—Tachycardia—Carmustine—brain cancer	0.000657	0.00146	CcSEcCtD
Prednisone—Oedema—Temozolomide—brain cancer	0.000651	0.00144	CcSEcCtD
Prednisone—Anaphylactic shock—Temozolomide—brain cancer	0.000651	0.00144	CcSEcCtD
Prednisone—Alopecia—Etoposide—brain cancer	0.000648	0.00144	CcSEcCtD
Prednisone—Infection—Temozolomide—brain cancer	0.000647	0.00143	CcSEcCtD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000644	0.00447	CbGpPWpGaD
Prednisone—Anorexia—Carmustine—brain cancer	0.000642	0.00142	CcSEcCtD
Prednisone—Nausea—Procarbazine—brain cancer	0.00064	0.00142	CcSEcCtD
Prednisone—Nervous system disorder—Temozolomide—brain cancer	0.000638	0.00141	CcSEcCtD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000635	0.00441	CbGpPWpGaD
Prednisone—Skin disorder—Temozolomide—brain cancer	0.000632	0.0014	CcSEcCtD
Prednisone—Hyperhidrosis—Temozolomide—brain cancer	0.000629	0.00139	CcSEcCtD
Prednisone—Anorexia—Temozolomide—brain cancer	0.000621	0.00137	CcSEcCtD
Prednisone—ABCB1—midbrain—brain cancer	0.000617	0.0056	CbGeAlD
Prednisone—Hypersensitivity—Hydroxyurea—brain cancer	0.000614	0.00136	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000614	0.00136	CcSEcCtD
Prednisone—Insomnia—Carmustine—brain cancer	0.000609	0.00135	CcSEcCtD
Prednisone—Paraesthesia—Carmustine—brain cancer	0.000605	0.00134	CcSEcCtD
Prednisone—ABCB1—spinal cord—brain cancer	0.000602	0.00546	CbGeAlD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.0006	0.00416	CbGpPWpGaD
Prednisone—Asthenia—Hydroxyurea—brain cancer	0.000598	0.00132	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000593	0.00131	CcSEcCtD
Prednisone—Ill-defined disorder—Etoposide—brain cancer	0.000592	0.00131	CcSEcCtD
Prednisone—Anaemia—Etoposide—brain cancer	0.00059	0.00131	CcSEcCtD
Prednisone—Insomnia—Temozolomide—brain cancer	0.000589	0.0013	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000588	0.00408	CbGpPWpGaD
Prednisone—Decreased appetite—Carmustine—brain cancer	0.000586	0.0013	CcSEcCtD
Prednisone—Paraesthesia—Temozolomide—brain cancer	0.000585	0.0013	CcSEcCtD
Prednisone—Constipation—Carmustine—brain cancer	0.000576	0.00128	CcSEcCtD
Prednisone—Malaise—Etoposide—brain cancer	0.000576	0.00128	CcSEcCtD
Prednisone—Vertigo—Etoposide—brain cancer	0.000573	0.00127	CcSEcCtD
Prednisone—Dyspepsia—Temozolomide—brain cancer	0.000573	0.00127	CcSEcCtD
Prednisone—HSD11B1—Metabolism—ENO2—brain cancer	0.00057	0.00396	CbGpPWpGaD
Prednisone—Diarrhoea—Hydroxyurea—brain cancer	0.00057	0.00126	CcSEcCtD
Prednisone—Decreased appetite—Temozolomide—brain cancer	0.000566	0.00125	CcSEcCtD
Prednisone—Fatigue—Temozolomide—brain cancer	0.000561	0.00124	CcSEcCtD
Prednisone—Loss of consciousness—Etoposide—brain cancer	0.000561	0.00124	CcSEcCtD
Prednisone—Constipation—Temozolomide—brain cancer	0.000557	0.00123	CcSEcCtD
Prednisone—Feeling abnormal—Carmustine—brain cancer	0.000555	0.00123	CcSEcCtD
Prednisone—Convulsion—Etoposide—brain cancer	0.000553	0.00123	CcSEcCtD
Prednisone—Hypertension—Etoposide—brain cancer	0.000551	0.00122	CcSEcCtD
Prednisone—Dizziness—Hydroxyurea—brain cancer	0.000551	0.00122	CcSEcCtD
Prednisone—Gastrointestinal pain—Carmustine—brain cancer	0.000551	0.00122	CcSEcCtD
Prednisone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000547	0.00379	CbGpPWpGaD
Prednisone—ABCB1—endocrine gland—brain cancer	0.000542	0.00492	CbGeAlD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00054	0.0012	CcSEcCtD
Prednisone—Discomfort—Etoposide—brain cancer	0.000537	0.00119	CcSEcCtD
Prednisone—Feeling abnormal—Temozolomide—brain cancer	0.000536	0.00119	CcSEcCtD
Prednisone—ABCB1—head—brain cancer	0.000535	0.00486	CbGeAlD
Prednisone—Body temperature increased—Carmustine—brain cancer	0.000533	0.00118	CcSEcCtD
Prednisone—Abdominal pain—Carmustine—brain cancer	0.000533	0.00118	CcSEcCtD
Prednisone—Gastrointestinal pain—Temozolomide—brain cancer	0.000532	0.00118	CcSEcCtD
Prednisone—Vomiting—Hydroxyurea—brain cancer	0.00053	0.00117	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000529	0.00367	CbGpPWpGaD
Prednisone—Rash—Hydroxyurea—brain cancer	0.000525	0.00116	CcSEcCtD
Prednisone—Dermatitis—Hydroxyurea—brain cancer	0.000525	0.00116	CcSEcCtD
Prednisone—Headache—Hydroxyurea—brain cancer	0.000522	0.00116	CcSEcCtD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000522	0.00362	CbGpPWpGaD
Prednisone—Anaphylactic shock—Etoposide—brain cancer	0.000521	0.00115	CcSEcCtD
Prednisone—Infection—Etoposide—brain cancer	0.000518	0.00115	CcSEcCtD
Prednisone—Urticaria—Temozolomide—brain cancer	0.000517	0.00115	CcSEcCtD
Prednisone—Abdominal pain—Temozolomide—brain cancer	0.000515	0.00114	CcSEcCtD
Prednisone—Body temperature increased—Temozolomide—brain cancer	0.000515	0.00114	CcSEcCtD
Prednisone—Tachycardia—Etoposide—brain cancer	0.000508	0.00113	CcSEcCtD
Prednisone—Skin disorder—Etoposide—brain cancer	0.000506	0.00112	CcSEcCtD
Prednisone—Hyperhidrosis—Etoposide—brain cancer	0.000504	0.00112	CcSEcCtD
Prednisone—Anorexia—Etoposide—brain cancer	0.000497	0.0011	CcSEcCtD
Prednisone—Hypersensitivity—Carmustine—brain cancer	0.000496	0.0011	CcSEcCtD
Prednisone—Nausea—Hydroxyurea—brain cancer	0.000495	0.0011	CcSEcCtD
Prednisone—ABCB1—central nervous system—brain cancer	0.000488	0.00443	CbGeAlD
Prednisone—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000487	0.00338	CbGpPWpGaD
Prednisone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000485	0.00336	CbGpPWpGaD
Prednisone—Asthenia—Carmustine—brain cancer	0.000483	0.00107	CcSEcCtD
Prednisone—Hypersensitivity—Temozolomide—brain cancer	0.00048	0.00106	CcSEcCtD
Prednisone—ABCB1—cerebellum—brain cancer	0.000477	0.00433	CbGeAlD
Prednisone—Paraesthesia—Etoposide—brain cancer	0.000468	0.00104	CcSEcCtD
Prednisone—Asthenia—Temozolomide—brain cancer	0.000467	0.00103	CcSEcCtD
Prednisone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000466	0.00324	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000463	0.00321	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000461	0.0032	CbGpPWpGaD
Prednisone—Diarrhoea—Carmustine—brain cancer	0.000461	0.00102	CcSEcCtD
Prednisone—Pruritus—Temozolomide—brain cancer	0.000461	0.00102	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000455	0.00315	CbGpPWpGaD
Prednisone—Decreased appetite—Etoposide—brain cancer	0.000453	0.001	CcSEcCtD
Prednisone—Fatigue—Etoposide—brain cancer	0.000449	0.000995	CcSEcCtD
Prednisone—Dizziness—Carmustine—brain cancer	0.000445	0.000987	CcSEcCtD
Prednisone—Constipation—Etoposide—brain cancer	0.000445	0.000987	CcSEcCtD
Prednisone—Diarrhoea—Temozolomide—brain cancer	0.000445	0.000987	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000431	0.00299	CbGpPWpGaD
Prednisone—Dizziness—Temozolomide—brain cancer	0.00043	0.000954	CcSEcCtD
Prednisone—Feeling abnormal—Etoposide—brain cancer	0.000429	0.000951	CcSEcCtD
Prednisone—Vomiting—Carmustine—brain cancer	0.000428	0.000949	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—brain cancer	0.000426	0.000944	CcSEcCtD
Prednisone—Rash—Carmustine—brain cancer	0.000425	0.000941	CcSEcCtD
Prednisone—Dermatitis—Carmustine—brain cancer	0.000424	0.00094	CcSEcCtD
Prednisone—Headache—Carmustine—brain cancer	0.000422	0.000935	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00042	0.00292	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000419	0.00291	CbGpPWpGaD
Prednisone—Vomiting—Temozolomide—brain cancer	0.000414	0.000917	CcSEcCtD
Prednisone—Urticaria—Etoposide—brain cancer	0.000414	0.000917	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—brain cancer	0.000412	0.000912	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—brain cancer	0.000412	0.000912	CcSEcCtD
Prednisone—Rash—Temozolomide—brain cancer	0.00041	0.000909	CcSEcCtD
Prednisone—Dermatitis—Temozolomide—brain cancer	0.00041	0.000908	CcSEcCtD
Prednisone—Headache—Temozolomide—brain cancer	0.000408	0.000903	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000404	0.0028	CbGpPWpGaD
Prednisone—Nausea—Carmustine—brain cancer	0.0004	0.000886	CcSEcCtD
Prednisone—ALB—Folate Metabolism—SOD2—brain cancer	0.000396	0.00275	CbGpPWpGaD
Prednisone—ABCB1—brain—brain cancer	0.000388	0.00352	CbGeAlD
Prednisone—Nausea—Temozolomide—brain cancer	0.000387	0.000857	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—brain cancer	0.000384	0.00085	CcSEcCtD
Prednisone—Asthenia—Etoposide—brain cancer	0.000374	0.000828	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.00037	0.00257	CbGpPWpGaD
Prednisone—Pruritus—Etoposide—brain cancer	0.000369	0.000816	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—brain cancer	0.000356	0.00079	CcSEcCtD
Prednisone—Dizziness—Etoposide—brain cancer	0.000344	0.000763	CcSEcCtD
Prednisone—Vomiting—Etoposide—brain cancer	0.000331	0.000734	CcSEcCtD
Prednisone—Rash—Etoposide—brain cancer	0.000328	0.000728	CcSEcCtD
Prednisone—Dermatitis—Etoposide—brain cancer	0.000328	0.000727	CcSEcCtD
Prednisone—Headache—Etoposide—brain cancer	0.000326	0.000723	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000325	0.00226	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000321	0.00223	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000317	0.0022	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000315	0.00218	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IRS2—brain cancer	0.000315	0.00218	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000314	0.00218	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000313	0.00217	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.00031	0.00215	CbGpPWpGaD
Prednisone—Nausea—Etoposide—brain cancer	0.000309	0.000685	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000295	0.00205	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000287	0.00199	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000283	0.00196	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.000281	0.00195	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000277	0.00192	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000273	0.0019	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MPL—brain cancer	0.000273	0.00189	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CG—brain cancer	0.000262	0.00182	CbGpPWpGaD
Prednisone—ALB—Hemostasis—S100A10—brain cancer	0.000261	0.00181	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000251	0.00174	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000239	0.00166	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000234	0.00163	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—RELA—brain cancer	0.000229	0.00159	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000227	0.00157	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000226	0.00157	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000223	0.00155	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000214	0.00148	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL2—brain cancer	0.000206	0.00143	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000206	0.00143	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000198	0.00138	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000197	0.00137	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000191	0.00133	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.000189	0.00131	CbGpPWpGaD
Prednisone—ALB—Hemostasis—BSG—brain cancer	0.000184	0.00128	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.000182	0.00126	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000181	0.00126	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP2C9—brain cancer	0.00018	0.00125	CbGpPWpGaD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000179	0.00124	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000177	0.00123	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	0.000177	0.00123	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000175	0.00122	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000168	0.00116	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT3—brain cancer	0.000164	0.00114	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000163	0.00113	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000157	0.00109	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL2—brain cancer	0.000156	0.00109	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000154	0.00107	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000153	0.00107	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—BSG—brain cancer	0.000153	0.00106	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000152	0.00106	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—brain cancer	0.00015	0.00104	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000144	0.001	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000144	0.000996	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000143	0.000993	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000141	0.000982	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000135	0.000935	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000133	0.000923	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—brain cancer	0.000132	0.000919	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—IDH1—brain cancer	0.000131	0.000912	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000129	0.000898	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TRPC6—brain cancer	0.000121	0.000838	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000117	0.000809	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000111	0.000773	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00011	0.000761	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000107	0.000743	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000104	0.000725	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ENO2—brain cancer	0.000104	0.000721	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—DNMT1—brain cancer	9.49e-05	0.000658	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	9.15e-05	0.000635	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VAV1—brain cancer	9.04e-05	0.000628	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2C9—brain cancer	8.78e-05	0.000609	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR2—brain cancer	8.52e-05	0.000591	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.52e-05	0.000591	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH2—brain cancer	8.07e-05	0.00056	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2C9—brain cancer	7.88e-05	0.000547	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	7.84e-05	0.000544	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2C9—brain cancer	7.69e-05	0.000534	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.52e-05	0.000522	CbGpPWpGaD
Prednisone—ALB—Metabolism—BSG—brain cancer	7.47e-05	0.000518	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.45e-05	0.000517	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SIRT1—brain cancer	6.86e-05	0.000476	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BSG—brain cancer	6.7e-05	0.000465	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	6.66e-05	0.000462	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.56e-05	0.000455	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BSG—brain cancer	6.54e-05	0.000454	CbGpPWpGaD
Prednisone—ALB—Metabolism—IDH1—brain cancer	6.42e-05	0.000446	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.04e-05	0.000419	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.9e-05	0.00041	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—IDH1—brain cancer	5.76e-05	0.0004	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—brain cancer	5.74e-05	0.000398	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—IDH1—brain cancer	5.63e-05	0.00039	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	5.58e-05	0.000387	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.23e-05	0.000363	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO2—brain cancer	5.08e-05	0.000352	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.96e-05	0.000344	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—brain cancer	4.77e-05	0.000331	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2C9—brain cancer	4.74e-05	0.000329	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.69e-05	0.000326	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO2—brain cancer	4.56e-05	0.000316	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO2—brain cancer	4.45e-05	0.000309	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—brain cancer	4.04e-05	0.00028	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BSG—brain cancer	4.03e-05	0.00028	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—IDH1—brain cancer	3.47e-05	0.000241	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—brain cancer	3.43e-05	0.000238	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO2—brain cancer	2.74e-05	0.00019	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—brain cancer	2.69e-05	0.000186	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—brain cancer	2.59e-05	0.00018	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—brain cancer	2.33e-05	0.000162	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—brain cancer	2.09e-05	0.000145	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—brain cancer	2.04e-05	0.000142	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—brain cancer	1.26e-05	8.72e-05	CbGpPWpGaD
